Skip to main content
WUHAN DR LASER TECHNOLOGY CORP.,LTD logo

WUHAN DR LASER TECHNOLOGY CORP.,LTD — Investor Relations & Filings

Ticker · 300776 ISIN · CNE100003KG5 LEI · 836800RAF3JVTRX1GR25 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 947 across all filing types
Latest filing 2019-04-29 Regulatory Filings
Country CN China
Listing Shenzhen Stock Exchange 300776

About WUHAN DR LASER TECHNOLOGY CORP.,LTD

https://www.drlaser.com.cn

Wuhan DR Laser Technology Corp., Ltd. specializes in the research, development, and manufacturing of precision laser processing equipment for the solar photovoltaic industry. The company provides advanced laser solutions designed to enhance solar cell efficiency. Its core product portfolio includes laser selective emitter (SE) systems, laser contact opening (LCO) equipment for PERC cells, and specialized laser doping (LD) technology. DR Laser also develops solutions for next-generation cell architectures such as TOPCon, HJT, and IBC. By integrating high-precision laser technology with automated production lines, the company enables manufacturers to optimize energy conversion rates and reduce costs. Its expertise extends to laser ablation, drilling, and repair processes, positioning it as a key supplier in the global renewable energy value chain.

Recent filings

Filing Released Lang Actions
中国证监会关于核准公司首次公开发行股票的批复
Regulatory Filings Classification · 95% confidence The document is an official approval letter from the China Securities Regulatory Commission (CSRC) regarding the initial public offering (IPO) of Wuhan Di'er Laser Technology Co., Ltd. It references the approval of the company's first public stock issuance and related regulatory compliance. The document is a formal regulatory approval notice rather than a financial report, earnings release, or management discussion. It does not contain financial statements or detailed financial analysis but is a regulatory filing related to capital market activities. Given the content and nature, it fits best under Regulatory Filings (RNS) as it is a formal regulatory approval document.
2019-04-29 Chinese
长江证券承销保荐有限公司关于公司首次公开发行股票并在创业板上市的发行保荐书
Regulatory Filings Classification · 95% confidence The document is a detailed underwriting and sponsorship report related to the initial public offering (IPO) and listing of Wuhan DR Laser Technology Corp., Ltd on the ChiNext board. It includes extensive information about the sponsor institution, the issuer's background, compliance with relevant laws and regulations, financial audit opinions, risk factors, and the sponsor's recommendation for the IPO. The document is titled as an "发行保荐书" (Issuance Sponsorship Letter), which is a formal underwriting and sponsorship report required for IPOs in China. It contains substantive financial data, audit opinions, and detailed analysis of the issuer's business and risks, indicating it is a comprehensive regulatory filing related to the IPO process but not a typical annual or quarterly report. This type of document is best classified under Regulatory Filings (RNS) as it is a regulatory submission related to securities issuance and listing, not an annual report, earnings release, or other specific report types. The document length (15,000 characters) and content confirm it is not a mere announcement or certification but a full regulatory filing.
2019-04-29 Chinese

Browse filings by year

8 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.